Rxo (RXO) Cash from Investing Activities (2021 - 2026)

Rxo (RXO) has reported Cash from Investing Activities for 6 consecutive years, with -$17.0 million the latest figure, recorded in Q1 2026.

• Cash from Investing Activities for Q1 2026 came in at -$17.0 million, up 32.0% year-over-year; the trailing twelve-month figure through Mar 2026 was -$63.0 million (up 94.16% YoY), and the FY2025 annual result was -$71.0 million, up 93.33% from the prior year.
• Cash from Investing Activities was -$17.0 million for Q1 2026 at Rxo, down from -$15.0 million in the prior quarter.
• Over five years, Cash from Investing Activities peaked at -$11.0 million in Q1 2024 and troughed at -$1.0 billion in Q3 2024.
• Average Cash from Investing Activities over 5 years is -$74.9 million, with a median of -$15.0 million recorded in 2025.
• Year-over-year, Cash from Investing Activities slumped 5321.05% in 2024 and soared 98.74% in 2025.
• Over 5 years, Cash from Investing Activities stood at -$18.0 million in 2022, then retreated by 5.56% to -$19.0 million in 2023, then jumped by 36.84% to -$12.0 million in 2024, then dropped by 25.0% to -$15.0 million in 2025, then decreased by 13.33% to -$17.0 million in 2026.
• Per Business Quant data, the three most recent Cash from Investing Activities figures were -$17.0 million in Q1 2026, -$15.0 million in Q4 2025, and -$13.0 million in Q3 2025.